Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Algernon Pharmaceuticals Inc
(OP:
AGNPF
)
0.0773
UNCHANGED
Streaming Delayed Price
Updated: 9:30 AM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
60
Open
0.0773
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0773
Today's Range
0.0773 - 0.0773
52wk Range
0.0353 - 0.1290
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
April 17, 2024
Via
Benzinga
DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design
April 03, 2024
Via
Benzinga
Performance
YTD
+20.59%
+20.59%
1 Month
-14.21%
-14.21%
3 Month
-29.02%
-29.02%
6 Month
+27.98%
+27.98%
1 Year
-40.08%
-40.08%
More News
Read More
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
August 14, 2023
Via
Benzinga
DMT As A Treatment For Stroke? This Company Is Closer To Launching Its Phase 2 Study
August 08, 2023
Via
Benzinga
Algernon Posts Mixed Bag Results From Mid Stage Chronic Cough Study
July 18, 2022
Via
Benzinga
DMT's Clinical Path For Treating TBI And Stroke: Phase 1 Dosing Finished As Phase 2 Gears Up
June 05, 2023
Via
Benzinga
How To Finance A Psychedelics Business? Learn From These Four Companies
April 04, 2023
Via
Benzinga
Intravenous DMT Therapy Seeks Ideal Dosage For Stroke And TBI Treatment
April 04, 2023
Via
Benzinga
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
March 07, 2023
Via
Benzinga
Algernon Pharmaceuticals AP-188 DMT Compound Shows Promise For The Treatment Of TBI
March 03, 2023
Via
Benzinga
Algernon Pharmaceuticals Goes 4:1 In Forward Share Split After Announcing New TBI Program
March 01, 2023
Via
Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
February 27, 2023
Via
Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
February 21, 2023
Via
Benzinga
Developing Psychedelic Treatments For Traumatic Brain Injury: Algernon Launches New Program
February 21, 2023
Via
Benzinga
Algernon Touts Positive Study Findings, Confirms Next Trial Phase With Escalated Dose
February 16, 2023
Via
Benzinga
A Psychedelic Program For Treatment Of Stroke: New Clinical Trial Begins Dosing
January 18, 2023
Via
Benzinga
Psychedelic Subsidiaries News: Blackhawk Spins Out Three Companies, Algernon Creates A New One
January 03, 2023
Via
Benzinga
EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
December 15, 2022
Via
Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
November 21, 2022
Via
Benzinga
Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon
November 16, 2022
Via
Benzinga
Algernon Pharmaceuticals: Advancing DMT into a Phase 1 Clinical Trial, CEO Clips Video
November 08, 2022
Via
Newsfile
Tackling Depression With Psychedelics: New Phase 2 Clinical Study Begins At Yale University
October 24, 2022
Via
Benzinga
A Foundational Study On Stroke Is Ready. Here Is Why It's Important
September 12, 2022
Via
Benzinga
Canadian Psychedelics Company To Begin First Global DMT Clinical Trial For Stroke Treatment
September 08, 2022
Via
Benzinga
Algernon Pharmaceuticals Closes Private Placement Round, Announces New Shareholder Distribution
August 23, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.